Home › Lupus Nephritis › Colorado › Aurora
Lupus Nephritis clinical trials in Aurora, CO
5 studies for Lupus Nephritis are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RecruitingPhase 2
- University of Colorado Denver, Aurora
VIBRANT: VIB4920 for Active Lupus Nephritis
RecruitingPhase 2
- University of Colorado School of Medicine: Division of Rheumatology, Aurora
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
RecruitingPhase 2
- Children's Hospital Colorado, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Colorado Denver, Aurora
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
RecruitingPhase 2
- Children's Hospital Colorado, Anchutz Medical Campus, Aurora
Lupus Nephritis trials in other cities
- New York City, NY10 studies
- Chicago, IL9 studies
- Atlanta, GA9 studies
- Houston, TX8 studies
- Durham, NC8 studies
- Boston, MA7 studies
- Philadelphia, PA7 studies
- San Francisco, CA7 studies
- St. Louis, MO5 studies
- Miami, FL5 studies
- Los Angeles, CA4 studies
- Cleveland, OH4 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer27 studies
- Metastatic Cancer25 studies
- Ovarian Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Prostate Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.